Table: begin end state 1 30 cytoplasmic 31 52 transmembrane 53 95 non-cytoplasmic 96 115 transmembrane 116 121 cytoplasmic 122 140 transmembrane 141 157 non-cytoplasmic 158 181 transmembrane 182 198 cytoplasmic 199 221 transmembrane 222 232 non-cytoplasmic 233 250 transmembrane 251 264 cytoplasmic 265 284 transmembrane 285 285 non-cytoplasmic 286 314 transmembrane 315 325 cytoplasmic 326 351 transmembrane 352 365 non-cytoplasmic
Input: >WP_090442761.1 NCBI__GCF_900100495.1:WP_090442761.1 MQVHTFKPDLPPPLLSVGVLGWLRANLFSSWFNTLLTLFAAYLVWLIVPPLLQWAFLDAD WVGTTRADCTGDGACWVFVQQRFSQFMYGFYPTELRWRVDLTLWLAVIGAAPLFIPQMPR KAVYGLGFLVVYPLLAYWLLHGGFFGLSTVSTSQWGGLMLTLVIASVGIAGALPLGIVLA LGRRSDMPAIRVICVTFIEFWRGVPLITVLFMSSVMLPLFLPEGLSFDKLMRALIGVILF QSAYIAEVVRGGLQAIPKGQYEAAAAMGLGYWRMMGLVILPQALKLVIPGIVNTFIALFK DTSLVIIIGLFDVLNSIKQATTDPAWLGMATEGYVFAALLFWIFCFGMSRYSMHLERKLD TGHKR
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server